146 related articles for article (PubMed ID: 18551124)
21. Initiation of prandial insulin therapy with AIR inhaled insulin or insulin lispro in patients with type 2 diabetes: A randomized noninferiority trial.
Gross JL; Nakano M; Colon-Vega G; Ortiz-Carasquillo R; Ferguson JA; Althouse S; Tobian JA; Berclaz PY; Milicevic Z
Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S27-34. PubMed ID: 19772446
[TBL] [Abstract][Full Text] [Related]
22. Diabetes-related distress, insulin dose, and age contribute to insulin-associated weight gain in patients with type 2 diabetes: results of a prospective study.
Jansen HJ; Vervoort GM; de Haan AF; Netten PM; de Grauw WJ; Tack CJ
Diabetes Care; 2014 Oct; 37(10):2710-7. PubMed ID: 25011948
[TBL] [Abstract][Full Text] [Related]
23. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
24. Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study.
Meneghini LF; Dornhorst A; Sreenan S;
Curr Med Res Opin; 2009 Apr; 25(4):1029-35. PubMed ID: 19281426
[TBL] [Abstract][Full Text] [Related]
25. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization.
Hayward RA; Manning WG; Kaplan SH; Wagner EH; Greenfield S
JAMA; 1997 Nov; 278(20):1663-9. PubMed ID: 9388085
[TBL] [Abstract][Full Text] [Related]
26. Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.
Mattoo V; Eckland D; Widel M; Duran S; Fajardo C; Strand J; Knight D; Grossman L; Oakley D; Tan M;
Clin Ther; 2005 May; 27(5):554-67. PubMed ID: 15978304
[TBL] [Abstract][Full Text] [Related]
27. A Tailored Cognitive-Behavioural Intervention Produces Comparable Reductions in Regimen-Related Distress in Adults With Type 2 Diabetes Regardless of Insulin Use: 12-Month Outcomes From the COMRADE Trial.
Lutes LD; Cummings DM; Littlewood K; Le MT; Kirian K; Patil S; Solar C; Carraway M; Hambidge B
Can J Diabetes; 2020 Aug; 44(6):530-536. PubMed ID: 32792107
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of switching from basal insulin to sitagliptin in Japanese type 2 diabetes patients.
Harashima SI; Tanaka D; Yamane S; Ogura M; Fujita Y; Murata Y; Seike M; Koizumi T; Aono M; Wang Y; Inagaki N
Horm Metab Res; 2013 Mar; 45(3):231-8. PubMed ID: 22972180
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with weight gain in people with type 2 diabetes starting on insulin.
Balkau B; Home PD; Vincent M; Marre M; Freemantle N
Diabetes Care; 2014 Aug; 37(8):2108-13. PubMed ID: 24824546
[TBL] [Abstract][Full Text] [Related]
30. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.
Kooy A; de Jager J; Lehert P; Bets D; Wulffelé MG; Donker AJ; Stehouwer CD
Arch Intern Med; 2009 Mar; 169(6):616-25. PubMed ID: 19307526
[TBL] [Abstract][Full Text] [Related]
31. Glycemic relapse in type 2 diabetes.
Graber AL; Shintani AK; Wolff K; Brown A; Elasy TA
Endocr Pract; 2006; 12(2):145-51. PubMed ID: 16690461
[TBL] [Abstract][Full Text] [Related]
32. Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.
Meneghini LF; Traylor L; Schwartz SL
Endocr Pract; 2010; 16(4):588-99. PubMed ID: 20350924
[TBL] [Abstract][Full Text] [Related]
33. Positive Impact of Continuous-Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure.
Yen DC; Watson MH; Burgess LD; Kuchibhatla M; Patel CB; Campbell KB; Vora AK
Pharmacotherapy; 2016 Dec; 36(12):1210-1216. PubMed ID: 27779786
[TBL] [Abstract][Full Text] [Related]
34. Glycemic, auxologic, and seasonal aspects of continuous subcutaneous insulin infusion therapy in children and young adults with type 1 diabetes.
Hathout EH; McClintock T; Sharkey J; Kytsenko D; Hartwick N; Hadley-Scofield M; Torgeson S; Mace JW
Diabetes Technol Ther; 2003; 5(2):175-81. PubMed ID: 12871607
[TBL] [Abstract][Full Text] [Related]
35. Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.
Buse JB; Bergenstal RM; Glass LC; Heilmann CR; Lewis MS; Kwan AY; Hoogwerf BJ; Rosenstock J
Ann Intern Med; 2011 Jan; 154(2):103-12. PubMed ID: 21138825
[TBL] [Abstract][Full Text] [Related]
36. Exenatide Once Weekly: Effectiveness, Tolerability, and Discontinuation Predictors in a Real-world Setting.
Di Dalmazi G; Coluzzi S; Baldassarre MPA; Sorbo SE; Dell'Aquila S; Febo F; Ginestra F; Graziano G; Rossi MC; Consoli A; Formoso G
Clin Ther; 2020 Sep; 42(9):1738-1749.e1. PubMed ID: 32753164
[TBL] [Abstract][Full Text] [Related]
37. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
[TBL] [Abstract][Full Text] [Related]
38. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
Waugh N; Cummins E; Royle P; Clar C; Marien M; Richter B; Philip S
Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668
[TBL] [Abstract][Full Text] [Related]
39. Weight gain and insulin requirement in type 2 diabetic patients during the first year after initiating insulin therapy dependent on baseline BMI.
Biesenbach G; Raml A; Alsaraji N
Diabetes Obes Metab; 2006 Nov; 8(6):669-73. PubMed ID: 17026491
[TBL] [Abstract][Full Text] [Related]
40. Long-term efficacy of triple oral therapy for type 2 diabetes mellitus.
Bell DS; Ovalle F
Endocr Pract; 2002; 8(4):271-5. PubMed ID: 12173913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
